Who owns PROTARA THERAPEUTIC INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Protara Therapeutic with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Protara Therapeutic stock

Who bought or sold PROTARA THERAPEUTIC INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Opaleye Management 2.7M $11M 0% Mar 2024
 View chart
Vanguard Group 428k $1.7M 0% Mar 2024
 View chart
Boxer Capital 209k $839k 0% Mar 2024
 View chart
Ikarian Capital 203k $813k 7% Mar 2024
 View chart
Baker Bros. Advisors 200k $801k 0% Mar 2024
 View chart
Privium Fund Management 120k $496k 0% Mar 2024
 View chart
Geode Capital Management 83k $333k 6% Mar 2024
 View chart
Bridgeway Capital Management 59k $237k -8% Mar 2024
 View chart
Citadel Advisors 32k $128k -17% Mar 2024
 View chart
BlackRock 31k $124k -11% Mar 2024
 View chart
LPL Financial 28k $112k 180% Mar 2024
 View chart
Two Sigma Advisers 27k $108k 0% Mar 2024
 View chart
Wolverine Trading 27k $107k 100% Mar 2024
 View chart
Boothbay Fund Management 23k $91k 20% Mar 2024
 View chart
Branch Banking & Trust Company 20k $80k 100% Mar 2024
 View chart
Two Sigma Investments 20k $79k -21% Mar 2024
 View chart
Bank of New York Mellon 18k $72k 0% Mar 2024
 View chart
Simplex Trading 18k $71k 100% Mar 2024
 View chart
Northern Trust 18k $71k -15% Mar 2024
 View chart
Two Sigma Securities 17k $70k 100% Mar 2024
 View chart
Dimensional Fund Advisors 12k $49k 100% Mar 2024
 View chart
Susquehanna International 11k $45k -68% Mar 2024
 View chart
Oppenheimer & Co 10k $40k 100% Mar 2024
 View chart
Acadian Asset Management 6.3k $25k 0% Mar 2024
 View chart
Royal Bank of Canada 4.0k $16k 448% Mar 2024
 View chart
UBS Group 3.7k $15k 307% Mar 2024
 View chart
Tower Research Capital 2.6k $10k -46% Mar 2024
 View chart
ADAR1 Capital Management 2.0k $8.0k -9% Mar 2024
 View chart
Wells Fargo & Company 570.00 $2.3k 0% Mar 2024
 View chart
Advisor Group Holdings 100.00 $401.000000 0% Mar 2024
 View chart
Jpmorgan Chase & Co 22.00 $88.000000 38% Mar 2024
 View chart
Qube Research & Technologies 2.00 $8.000000 0% Mar 2024
 View chart

Who sold out of Protara Therapeutic?

Fund or Company Name Date Sold Shares Held Valued At
Assenagon Asset Management Dec 2023 16k $30k
Millennium Management Dec 2023 12k $22k
Bank of America Corporation Dec 2023 6.00 $10.999800